Jushi Holdings (JUSHF) Retained Earnings (2021 - 2026)
Jushi Holdings (JUSHF) posted quarterly Retained Earnings of -$654.4 million for Q2 2026, down 11.3% year-over-year from -$737.7 million in Q2 2025, and down 1.13% quarter-over-quarter from -$647.1 million in Q1 2026.
Jushi Holdings (JUSHF) Retained Earnings (2021 - 2026) Analysis & Trends
Jushi Holdings (JUSHF) has reported Retained Earnings for 6 consecutive years, with -$654.4 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Retained Earnings fell 11.3% year-over-year to -$654.4 million; the TTM figure through Jun 2026 stood at -$654.4 million (down 11.3% YoY), while the FY2025 annual figure was -$627.2 million, down 12.28% from the prior year.
- Retained Earnings declined to -$654.4 million in Q2 2026 per JUSHF's latest filing, from -$647.1 million in the prior quarter.
- Across five years, Retained Earnings topped out at $501.1 million in Q3 2023 and bottomed at -$654.4 million in Q2 2026.
- Historically, Retained Earnings has averaged -$201.8 million across 5 years, with a median of -$530.1 million in 2024.
- Annual changes were most pronounced in 2022 — Retained Earnings advanced 15.83% — and 2024, when it sank 209.0%.
- Jushi Holdings' Retained Earnings stood at $492.0 million in 2022, then plunged by 203.62% to -$509.8 million in 2023, then decreased by 9.57% to -$558.6 million in 2024, then slipped by 12.28% to -$627.2 million in 2025, then fell by 4.33% to -$654.4 million in 2026.
- Business Quant data shows JUSHF's Retained Earnings at -$654.4 million in Q2 2026, -$647.1 million in Q1 2026, and -$627.2 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | 37.15 Bn |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 28.26 Bn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | 14.65 Bn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | 4.18 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 9.16 Bn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 18.56 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 724.00 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 8.88 Bn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 3.75 Bn |
| 10 | Jushi Holdings | 83.87 Mn | 50.54 Mn | 31.53 Mn | -654.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -654.39 Mn |
| Mar 31, 2026 | -647.06 Mn |
| Dec 31, 2025 | -627.21 Mn |
| Sep 30, 2025 | -611.66 Mn |
| Jun 30, 2025 | -587.97 Mn |
| Mar 31, 2025 | -575.64 Mn |
| Dec 31, 2024 | -558.62 Mn |
| Sep 30, 2024 | -546.15 Mn |
| Jun 30, 2024 | -530.14 Mn |
| Mar 31, 2024 | -528.20 Mn |
| Dec 31, 2023 | -509.84 Mn |
| Sep 30, 2023 | 501.06 Mn |
| Jun 30, 2023 | 500.09 Mn |
| Mar 31, 2023 | 494.33 Mn |
| Dec 31, 2022 | 492.02 Mn |
| Sep 30, 2022 | 483.65 Mn |
| Jun 30, 2022 | 475.59 Mn |
| Dec 31, 2021 | 424.79 Mn |